Morgan Stanley’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $47.4M | Buy |
|
|||||
|
2025
Q1 | $8.33M | Sell |
|
|||||
|
2024
Q4 | $8.79M | Buy |
|
|||||
|
2024
Q3 | $7.94M | Buy |
|
|||||
|
2024
Q2 | $7.32M | Sell |
|
|||||
|
2024
Q1 | $9.49M | Sell |
|
|||||
|
2023
Q4 | $14.5M | Buy |
|
|||||
|
2023
Q3 | $7.65M | Buy |
|
|||||
|
2023
Q2 | $5.26M | Sell |
|
|||||
|
2023
Q1 | $7.94M | Sell |
|
|||||
|
2022
Q4 | $9.38M | Buy |
|
|||||
|
2022
Q3 | $7.13M | Sell |
|
|||||
|
2022
Q2 | $14.5M | Buy |
|
|||||
|
2022
Q1 | $3.31M | Buy |
|
|||||
|
2021
Q4 | $3.17M | Sell |
|
|||||
|
2021
Q3 | $4.36M | Buy |
|
|||||
|
2021
Q2 | $4.21M | Buy |
|
|||||
|
2021
Q1 | $2.27M | Sell |
|
|||||
|
2020
Q4 | $2.37M | Sell |
|
|||||
|
2020
Q3 | $2.38M | Buy |
|
|||||
|
2020
Q2 | $1.8M | Buy |
|
|||||
|
2020
Q1 | $1.5M | Sell |
|
|||||
|
2019
Q4 | $2.17M | Buy |
|
|||||
|
2019
Q3 | $1.41M | Buy |
|
|||||
|
2019
Q2 | $1.39M | Sell |
|
|||||
|
2019
Q1 | $1.52M | Sell |
|
|||||
|
2018
Q4 | $1.42M | Sell |
|
|||||
|
2018
Q3 | $1.92M | Sell |
|
|||||
|
2018
Q2 | $3.64M | Buy |
|
|||||
|
2018
Q1 | $3.49M | Sell |
|
|||||
|
2017
Q4 | $5.44M | Buy |
|
|||||
|
2017
Q3 | $4.05M | Sell |
|
|||||
|
2017
Q2 | $4.69M | Sell |
|
|||||
|
2017
Q1 | $5M | Sell |
|
|||||
|
2016
Q4 | $5.03M | Buy |
|
|||||
|
2016
Q3 | $3.93M | Sell |
|
|||||
|
2016
Q2 | $10.7M | Sell |
|
|||||
|
2016
Q1 | $18.7M | Sell |
|
|||||
|
2015
Q4 | $22.7M | Sell |
|
|||||
|
2015
Q3 | $27.3M | Sell |
|
|||||
|
2015
Q2 | $33.4M | Buy |
|
|||||
|
2015
Q1 | $8.55M | Buy |
|
|||||
|
2014
Q4 | $6.01M | Buy |
|
|||||
|
2014
Q3 | $5.66M | Sell |
|
|||||
|
2014
Q2 | $6.06M | Buy |
|
|||||
|
2014
Q1 | $5.56M | Sell |
|
|||||
|
2013
Q4 | $5.07M | Sell |
|
|||||
|
2013
Q3 | $4.7M | Sell |
|
|||||
|
2013
Q2 | $4.98M | Buy |
|